Heartburn drug suspended from sale

Heartburn drug suspended from sale - US retailer CVS has become the latest to suspend the sale of a heartburn drug being investigated for links to cancer. The move comes after concern in several countries over the presence of impurities in Zantac and other ranitidine products. Canada and France have already announced Zantac recalls. The US and the European Union are investigating. Health authorities say there is no immediate risk, but patients have been advised to consult a doctor who can prescribe alternatives to ranitidine.

Last local news

Evening Update Friday 30th May 2025

Another power outage has hit three towns on Friday morning, the 30th of May, affecting 120 homes in the Alpes-Maritimes.... Evening Update Friday 30th May 2025 Read More

30/05/2025

French and Riviera News Friday 30th May 2025

France’s health minister has announced that France will introduce a nationwide ban on smoking in outdoor public areas commonly visited by children, st... French and Riviera News Friday 30th May 2025 Read More

30/05/2025

Evening Update Thursday 29th May 2025

The Var department has experienced its first "tropical night" of the season, with temperatures not dropping below 25°C at 3 am, particularly in Hyères... Evening Update Thursday 29th May 2025 Read More

29/05/2025

S.B.M. Group reports strong growth and record results for 2024/2025

The Société des Bains de Mer (S.B.M.) has announced solid financial results for the 2024/2025 fiscal year, ending March 31, 2025, with revenue rising ... S.B.M. Group reports strong growth and record results for 2024/2025 Read More

29/05/2025

French and Riviera News Thursday 29th May 2025

France is set to experience record-breaking heat over the Ascension Day holiday, with tomorrow, Friday, May 30th, expected to be the hottest day of th... French and Riviera News Thursday 29th May 2025 Read More

29/05/2025